Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 63, Issue 22, Pages 13205-13227Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acs.jmedchem.0c00626
Keywords
-
Categories
Funding
- National Key Research and Development Program of China [2017YFD0501404]
- Guangdong Special Support Program Innovation Team [2019BT02N054]
- Special Technologies R&D Program for COVID-19 by Education Commission of Guangdong Province [2020KZDZX1039]
- Pearl River S&T Nova Program of Guangzhou [201806010115]
- Special Technologies R&D Program for COVID-19 of Guangdong Province [2020A111128014]
Ask authors/readers for more resources
The coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to more than 20 million people infected worldwide with an average mortality rate of 3.6%. This virus poses major challenges to public health, as it not only is highly contagious but also can be transmitted by asymptomatic infected individuals. COVID-19 is clinically difficult to manage due to a lack of specific antiviral drugs or vaccines. In this article, Chinese therapy strategies for treating COVID-19 patients, including current applications of traditional Chinese medicine (TCM), are comprehensively reviewed. Furthermore, 72 small molecules from natural products and TCM with reported antiviral activity against human coronaviruses (CoVs) are identified from published literature, and their potential applications in combating SARS-CoV-2 are discussed. Among these, the clinical efficacies of some accessible drugs such as remdesivir (RDV) and favipiravir (FPV) for COVID-19 are emphatically summarized. We hope this review provides a foundation for managing the worsening pandemic and developing antivirals against SARS-CoV-2.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available